Ownership
Private
Employees
~50
Therapeutic Areas
Other
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Medical deviceBiologic (including orthobiologics and bone substitute materials)Small molecule (pharmaceuticals)Combination product (device + drug/biologic)

PBC BioMed General Information

PBC BioMed accelerates the design, development, and manufacturing of innovative medical devices, biomaterials, pharmaceuticals and combination products. The company provides consultancy services across R&D through commercialization. It holds ISO certifications for quality management in both consultancy and manufacturing. It has developed proprietary tools like AIM to support innovation lifecycle management. PBC BioMed also acts as Marketing Authorization Holder for several over-the-counter healthcare products in Europe/UK including Nelsons Arnicare Arnica Cream and Teetha Teething Granules/Gel. The company spun out CelgenTek—an orthobiologics business acquired by ZimmerBiomet—but does not appear to have its own clinical pipeline of drugs or biologics at present.

Contact Information

Primary Industry
Consulting
Corporate Office
Shannon,
Ireland

Drug Pipeline

OssiVet
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to PBC BioMed's pipeline data

Book a demo

Key Partnerships

Notable partnerships with small-to-large companies across MedTech/pharma sectors as well as academic institutions/universities/government-funded projects. Specific partners are not named.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

PBC BioMed Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view PBC BioMed's complete valuation and funding history, request access »

PBC BioMed Financial Metrics